AAAAAA

   
Results: 1-25 | 26-50 | 51-61 |
Results: 51-61/61
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY (MNGIE) - CLINICAL, BIOCHEMICAL, AND GENETIC FEATURES OF AN AUTOSOMAL RECESSIVE MITOCHONDRIAL DISORDER
Authors: HIRANO M SILVESTRI G BLAKE DM LOMBES A MINETTI C BONILLA E HAYS AP LOVELACE RE BUTLER I BERTORINI TE THRELKELD AB MITSUMOTO H SALBERG LM ROWLAND LP DIMAURO S
Citation: M. Hirano et al., MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY (MNGIE) - CLINICAL, BIOCHEMICAL, AND GENETIC FEATURES OF AN AUTOSOMAL RECESSIVE MITOCHONDRIAL DISORDER, Neurology, 44(4), 1994, pp. 721-727
MUTATIONS IN THE CU-ZN SUPEROXIDE-DISMUTASE GENE IN FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS
Authors: SIDDIQUE T DENG HX HENTATI A TANDON R PERICAKVANCE MA LAING NG ROOS RP CAYABYAB A GERZFELDT B HUNG WY DENG G NEARING R WARNER C MITSUMOTO H SORIANO E SMYTH C
Citation: T. Siddique et al., MUTATIONS IN THE CU-ZN SUPEROXIDE-DISMUTASE GENE IN FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS, Annals of neurology, 34(2), 1993, pp. 303-304
BRAIN-DERIVED NEUROTROPHIC FACTOR ATTENUATES NEUROMUSCULAR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE
Authors: IKEDA K MITSUMOTO H CEDARBAUM JM WONG V LINDSAY RM
Citation: K. Ikeda et al., BRAIN-DERIVED NEUROTROPHIC FACTOR ATTENUATES NEUROMUSCULAR DYSFUNCTION IN WOBBLER MOUSE MOTOR-NEURON DISEASE, Annals of neurology, 34(2), 1993, pp. 304-304
IN-VIVO AND IN-VITRO MUSCLE TENSIONS IN WOBBLER MOUSE MOTOR-NEURON DISEASE
Authors: IKEDA K MITSUMOTO H
Citation: K. Ikeda et H. Mitsumoto, IN-VIVO AND IN-VITRO MUSCLE TENSIONS IN WOBBLER MOUSE MOTOR-NEURON DISEASE, Muscle & nerve, 16(9), 1993, pp. 979-981
RETARDATION OF FAST AXONAL-TRANSPORT IN WOBBLER MICE
Authors: MITSUMOTO H KURAHASHI K JACOB JM MCQUARRIE IG
Citation: H. Mitsumoto et al., RETARDATION OF FAST AXONAL-TRANSPORT IN WOBBLER MICE, Muscle & nerve, 16(5), 1993, pp. 542-547
OBTURATOR MONONEUROPATHY CAUSED BY PELVIC CANCER - 6 CASES
Authors: ROGERS LR BORKOWSKI GP ALBERS JW LEVIN KH BAROHN RJ MITSUMOTO H
Citation: Lr. Rogers et al., OBTURATOR MONONEUROPATHY CAUSED BY PELVIC CANCER - 6 CASES, Neurology, 43(8), 1993, pp. 1489-1492
TREATMENT OF MYASTHENIA-GRAVIS BY IMMUNOADSORPTION OF PLASMA
Authors: GROB D HOCH B SHIRAZIAN D BENDER A GREENBERG M SIMPSON D MITSUMOTO H KOO A NAKAYAMA S
Citation: D. Grob et al., TREATMENT OF MYASTHENIA-GRAVIS BY IMMUNOADSORPTION OF PLASMA, Neurology, 43(4), 1993, pp. 181-181
MORPHOLOGICAL-CHANGES CORRELATE WITH FUNCTIONAL IMPROVEMENT FOLLOWINGCILIARY NEUROTROPHIC FACTOR (CNTF) TREATMENT OF MOTOR-NEURON DISEASE IN THE WOBBLER MOUSE
Authors: IKEDA K MITSUMOTO H WONG V CEDARBAUM JM LINDSAY RM
Citation: K. Ikeda et al., MORPHOLOGICAL-CHANGES CORRELATE WITH FUNCTIONAL IMPROVEMENT FOLLOWINGCILIARY NEUROTROPHIC FACTOR (CNTF) TREATMENT OF MOTOR-NEURON DISEASE IN THE WOBBLER MOUSE, Neurology, 43(4), 1993, pp. 321-321
MNGIE (MITOCHONDRIAL NEUROPATHY, GASTROINTESTINAL ENCEPHALOPATHY) - CLINICAL, BIOCHEMICAL, AND GENETIC FEATURES
Authors: HIRANO M SILVESTRI G BUTLER I MITSUMOTO H BERTORINI TE THRELKELD AB LOVELACE RE DIMAURO S
Citation: M. Hirano et al., MNGIE (MITOCHONDRIAL NEUROPATHY, GASTROINTESTINAL ENCEPHALOPATHY) - CLINICAL, BIOCHEMICAL, AND GENETIC FEATURES, Neurology, 43(4), 1993, pp. 402-402
CILIARY NEUROTROPHIC FACTOR (CNTF) IMPROVES NEUROMUSCULAR FUNCTION AND MUSCLE STRENGTH FOLLOWING ONSET OF MOTOR-NEURON DISEASE IN THE WOBBLER MOUSE
Authors: MITSUMOTO H IKEDA K WONG V CEDARBAUM JM LINDSAY RM
Citation: H. Mitsumoto et al., CILIARY NEUROTROPHIC FACTOR (CNTF) IMPROVES NEUROMUSCULAR FUNCTION AND MUSCLE STRENGTH FOLLOWING ONSET OF MOTOR-NEURON DISEASE IN THE WOBBLER MOUSE, Neurology, 43(4), 1993, pp. 415-415
RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES
Authors: BROOKS BR SANJAK M MITSUMOTO H SZIRONY K NEVILLE H RINGEL S BRINKMANN J PESTRONK A FLORENCE J CEDARBAUM JM CHARATAN M STAMBLER N WITTES J BRITTAIN E
Citation: Br. Brooks et al., RECOMBINANT HUMAN CILIARY NEUROTROPHIC FACTOR (RHCNTF) IN AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) PATIENTS - PHASE-I-II SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDIES, Neurology, 43(4), 1993, pp. 416-416
Risultati: 1-25 | 26-50 | 51-61 |